EPB41
(Erythrocyte Membrane Protein Band 4.1 (Elliptocytosis 1, RH-Linked) (EPB41))
Protein Region
N-Term
Spezies
Human
Quelle
Synthetic
Applikation
Blocking Peptide (BP), Western Blotting (WB)
Produktmerkmale
This is a synthetic peptide designed for use in combination with anti-EPB41 antibody (Catalog #: ARP42747_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
EPB41
Reaktivität: Human, Rind (Kuh), Maus
Wirt: Synthetic
BP
Applikationshinweise
Each Investigator should determine their own optimal working dilution for specific applications.
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Lyophilized
Rekonstitution
Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
Konzentration
1 mg/mL
Buffer
Final peptide concentration is 1 mg/mL in PBS.
Handhabung
Avoid repeated freeze-thaw cycles.
Lagerung
-20 °C
Informationen zur Lagerung
For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
Target
EPB41
(Erythrocyte Membrane Protein Band 4.1 (Elliptocytosis 1, RH-Linked) (EPB41))
Hintergrund
Elliptocytosis is a hematologic disorder characterized by elliptically shaped erythrocytes and a variable degree of hemolytic anemia. Inherited as an autosomal dominant, elliptocytosis results from mutation in any one of several genes encoding proteins of
Alias Symbols: 4.1R, EL1, HE
Protein Interaction Partner: ACTA1,APP,BCAM,C2CD2L,CASK,CD44,CENPJ,CLNS1A,CRYAB,DLG1,DRD2,DRD3,EGFR,EIF3G,EPB42,FKBP2,GDI1,GYPC,KPNA2,MACROD1,MYL1,NUMA1,PRKCB,SEC14L1,SLC4A1,SMAD3,SPTAN1,SPTB,SPTBN1,TJP2,TPM1,TUBA4A,U2AF1,U2AF2,YWHAB,YWHAQ,CALR,CASK,CDK2,CENPJ,DCTN1,DLG1,DYNC1H1,ECHS1,EIF3G,KPNA2,MYH9,NPPA,NUMA1,PAICS,PFAS,SPTAN1,SPTB,TAGLN2,TJP2,VARS